Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders

Archives of General Psychiatry

Volumn 64, Issue 10, 2007, Pages 1189-1195

  Dempster, Emma L ^a   Burcescu, Irina ^a   Wigg, Karen ^a   Kiss, Eniko ^d,g   Baji, Ildiko ^e,h   Gadoros, Julia ^e,h   Tamás, Zsuzsanna ^e,h   Kennedy, James L ^b   Vetró, Ágnes ^d,g   Kovacs, Maria ^f   Barr, Cathy L ^a,c   Kapornai, Krisztina ^g   Benák, István ^g   Osváth, Viola Kothencné ^g   Dombovári, Edit ^g   Kaczvinszky, Emília ^g   Daróczy, Gabriella ^g   Mayer, László ^g   Besnyö, Márta ^e   Székely, Judit ^h  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF SZEGED   (Hungary)

^e Vadaskert Hospital   (Hungary)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SZEGED   (Hungary)

^h SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN V1B RECEPTOR;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PROTEIN DOMAIN; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34948879533     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.64.10.1189     Document Type: Article

References (63)

1. Scott LV, Dinan TG. Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord. 2002;72(2):113-124.
2. Watson S, Gallagher P, Ferrier IN, Young AH. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. J Psychiatr Res. 2006;40(4):353-359.
3. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav. 2003;43(1):60-66.
4. Birmaher B, Ryan ND, Dahl R, Rabinovich H, Ambrosini P, Williamson DE, Novacenko H, Nelson B, Lo ES, Puig-Antich J. Dexamethasone suppression test in children with major depressive disorder. J Am Acad Child Adolesc Psychiatry. 1992;31(2):291-297.
5. Puig-Antich J, Dahl R, Ryan N, Novacenko H, Goetz D, Goetz R, Twomey J, Klepper T. Cortisol secretion in prepubertal children with major depressive disorder: episode and recovery. Arch Gen Psychiatry. 1989;46(9):801-809.
6. Birmaher B, Dahl RE, Perel J, Williamson DE, Nelson B, Stull S, Kaufman J, Waterman GS, Rao U, Nguyen N, Puig-Antich J, Ryan ND. Corticotropin-releasing hormone challenge in prepubertal major depression. Biol Psychiatry. 1996;39(4):267-277.
7. Dahl RE, Kaufman J, Ryan ND, Perel J, al-Shabbout M, Birmaher B, Nelson B, Puig-Antich J. The dexamethasone suppression test in children and adolescents: a review and a controlled study. Biol Psychiatry. 1992;32(2):109-126.
8. Ashman SB, Dawson G, Panagiotides H, Yamada E, Wilkinson CW. Stress hormone levels of children of depressed mothers. Dev Psychopathol. 2002;14(2):333-349.
9. Luby JL, Heffelfinger A, Mrakotsky C, Brown K, Hessler M, Spitznagel E. Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry. 2003;60(12):1248-1255.
10. Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology. 2006;31(1):212-220.
11. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol. 1994;15(4):321-350.
12. Landgraf R. The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets. 2006;5(2):167-179.
13. Gold PW, Goodwin FK, Reus VI. Vasopressin in affective illness. Lancet. 1978;1(8076):1233-1236.
14. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept. 2000;96(1-2):23-29.
15. Aguilera G, Pham Q, Rabadan-Diehl C. Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness. J Neuroendocrinol. 1994;6(3):299-304.
16. Rabadan-Diehl C, Aguilera G. Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C. Endocrinology. 1998;139(7):3220- 3226.
17. Tanoue A, Ito S, Honda K, Oshikawa S, Kitagawa Y, Koshimizu TA, Mori T, Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest. 2004;113(2):302-309.
18. Itoh S, Yamada S, Mori T, Miwa T, Tottori K, Uwahodo Y, Yamamura Y, Fukuda M, Yamamoto K, Tanoue A, Tsujimoto G. Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor. Am J Physiol Endocrinol Metab. 2006;291(1):E147-E151.
19. Liebsch G, Wotjak CT, Landgraf R, Engelmann M. Septal vasopressin modulates anxiety-related behaviour in rats. Neurosci Lett. 1996;217(2-3):101-104.
20. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A. 2002;99(9):6370-6375.
21. Stemmelin J, Lukovic L, Salome N, Griebel G. Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415. Neuropsychopharmacology. 2005;30(1):35-42.
22. van West D, Del-Favero J, Aulchenko Y, Oswald P, Souery D, Forsgren T, Sluijs S, Bel-Kacem S, Adolfsson R, Mendlewicz J, Van Duijn C, Deboutte D, Van Broeckhoven C, Claes S. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol Psychiatry. 2004;9(3):287-292.
23. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem. 1994;269(43):27088-27092.
24. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, Rollins DY, Moses T, Sanders AR, Karkera JD, Esterling LE, Zeng J, Ferraro TN, Guroff JJ, Kazuba D, Maxwell ME, Nurnberger JI Jr, Gershon ES. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci U S A. 1999;96(10):5604-5609.
25. Nash MW, Huezo-Diaz P, Williamson RJ, Sterne A, Purcell S, Hoda F, Cherny SS, Abecasis GR, Prince M, Gray JA, Ball D, Asherson P, Mann A, Goldberg D, McGuffin P, Farmer A, Plomin R, Craig IW, Sham PC. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum Mol Genet. 2004;13(19):2173-2182.
26. Talbot CJ, Nicod A, Cherny SS, Fulker DW, Collins AC, Flint J. High-resolution mapping of quantitative trait loci in outbred mice. Nat Genet. 1999;21(3):305-308.
27. Turri MG, Talbot CJ, Radcliffe RA, Wehner JM, Flint J. High-resolution mapping of quantitative trait loci for emotionality in selected strains of mice. Mamm Genome. 1999;10(11):1098-1101.
28. Liu X, Gentzler AL, Tepper P, Kiss E, Kothencne VO, Tamas Z, Vetro A, Kovacs M. Clinical features of depressed children and adolescents with various forms of suicidality. J Clin Psychiatry. 2006;67(9):1442-1450.
29. Shaw DS, Schonberg M, Sherrill J, Huffman D, Lukon J, Obrosky D, Kovacs M. Responsivity to offspring's expression of emotion among childhood-onset depressed mothers. J Clin Child Adolesc Psychol. 2006;35(4):490-503.
30. Pérez-Edgar K, Fox NA, Cohn JF, Kovacs M. Behavioral and electrophysiological markers of selective attention in children of parents with a history of depression. Biol Psychiatry. 2006;60(10):1131-1138.
31. Forbes EE, Shaw DS, Fox NA, Cohn JF, Silk JS, Kovacs M. Maternal depression, child frontal asymmetry, and child affective behavior as factors in child behavior problems. J Child Psychol Psychiatry. 2006;47(1):79-87.
32. Sherrill JT, Kovacs M. Interview schedule for children and adolescents (ISCA). J Am Acad Child Adolesc Psychiatry. 2000;39(1):67-75.
33. Burcescu I, Wigg K, King N, Vetro A, Kiss E, Katay L, Kennedy JL, Kovacs M, Barr CL. Association study of CREB1 and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet. 2005;137(1):45-50.
34. Kapornai K, Gentzler AL, Tepper P, Kiss E, Mayer L, Tamas Z, Kovacs M, Vetro A; International Consortium for Childhood-Onset Mood Disorders. Early developmental characteristics and features of major depressive disorder among child psychiatric patients in Hungary. J Affect Disord. 2007;100(1-3):91-101.
35. Kiss E, Gentzler AM, George C, Kapornai K, Tamas Z, Kovacs M, Vetro A. Factors influencing mother-child reports of depressive symptoms and agreement among clinically referred depressed youngsters in Hungary. J Affect Disord. 2007;100(1-3):143-151.
36. Kovacs M. The Emanuel Miller Memorial Lecture 1994: depressive disorders in childhood: an impressionistic landscape. J Child Psychol Psychiatry. 1997;38(3):287-298.
37. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry. 2001;158(1):125-127.
38. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60(5):497-502.
39. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
40. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30(1):97-101.
41. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003;25(2):115-121.
42. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet. 1999;65(4):1170-1177.
43. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265.
44. Iida A, Saito S, Sekine A, Kataoka Y, Tabei W, Nakamura Y. Catalog of 300 SNPs in 23 genes encoding G-protein coupled receptors. J Hum Genet. 2004;49(4):194-208.
45. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30(17):3894-3900.
46. Derick S, Pena A, Durroux T, Wagnon J, Serradeil-Le Gal C, Hibert M, Rognan D, Guillon G. Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor. Mol Endocrinol. 2004;18(11):2777-2789.
47. Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry. 2006;163(1):109-114.
48. Zubenko GS, Maher B, Hughes HB III, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet. 2003;123(1):1-18.
49. McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, Gill M, Korszun A, Maier W, Middleton L, Mors O, Owen MJ, Perry J, Preisig M, Reich T, Rice J, Rietschel M, Jones L, Sham P, Farmer AE. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet. 2005;14(22):3337-3345.
50. Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Takao H, Minabe Y, Nakatani N, Higuchi T, Detera-Wadleigh SD, Yoshikawa T. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry. 2006;60(2):192-201.
51. Halbreich U. Gonadal hormones, reproductive age, and women with depression. Arch Gen Psychiatry. 2000;57(12):1163-1164.
52. Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med. 1998;28(1):51-61.
53. Angold A, Costello EJ, Erkanli A, Worthman CM. Pubertal changes in hormone levels and depression in girls. Psychol Med. 1999;29(5):1043- 1053.
54. Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs. 2001;15(10):797-817.
55. René P, Lenne F, Ventura MA, Bertagna X, de Keyzer Y. Nucleotide sequence and structural organization of the human vasopressin pituitary receptor (V3) gene. Gene. 2000;241(1):57-64.
56. Miller WJ, Suzuki S, Miller LK, Handa R, Uht RM. Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway. J Neurosci. 2004;24(47):10628-10635.
57. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest. 1993;92(4):1896-1902.
58. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev. 2003;(24):668-693.
59. Błogowska A, Rzepka-Gorska I, Krzyzanowska-Swiniarska B, Zoltowski S, Kosmowska B. Leptin, neuropeptide Y, beta-endorphin, gonadotropin, and estradiol levels in girls before menarche. Gynecol Endocrinol. 2003;17(1):7-12.
60. Collaer ML, Hines M. Human behavioral sex differences: a role for gonadal hormones during early development? Psychol Bull. 1995;118(1):55-107.
61. De Vries GJ, Panzica GC. Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints. Neuroscience. 2006;138(3):947-955.
62. Fliers E, Guldenaar SE, van , de WN, Swaab DF. Extrahypothalamic vasopressin and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res. 1986;375(2):363-367.
63. Thompson RR, George K, Walton JC, Orr SP, Benson J. Sex-specific influences of vasopressin on human social communication. Proc Natl Acad Sci U S A. 2006;103(20):7889-7894.